Dr Karthik Ramasamy

MBBS, MRCP, FRCPath, PHD


Special clinical interest in haemato-oncology, myeloma, other plasma cell dyscrasias, stem cell transplantation and cancer clinical trials.

LANGUAGES

English

Professional profile

Dr Karthik Ramasamy has established a strong myeloma and other plasma cell dyscrasias clinical practice in Oxford. He is the Lead Clinician for myeloma and other plasma dyscrasias in Thames Valley Strategic Clinical Network. He is a Chief Investigator of national myeloma studies and Principal Investigator of a number of myeloma trials.

Dr Ramasamy has recently been appointed as Divisional Lead of Cancer Research across Thames Valley and South Midlands Research Network.

Year qualified
2003

Current NHS post
Consultant Haematologist, Oxford University Hospitals NHS Trust

Professional memberships
Member, National Cancer Research Institute.
Myeloma Studies Group.
MCTN Meyeloma UK.
Exec, UK Myeloma Forum.
Member, American Society for Haematology.
Member, British Society of Haematology.
Member, British Society of Bone and Marrow Transplantation.

 

Specialities

  • Oncology

Centres